Prof. Afolake Arowolo is a Specialist Scientist at the Biomedical Research and Innovation Platform of the South African Medical Research Council (SAMRC) and an Honorary Associate Professor in the Department of Medicine at the University of Cape Town. She holds a PhD in Biochemistry from Rhodes University and an Executive MBA. Her research focuses on molecular pharmacology, inflammation, fibrosis and cardiometabolic disease, with particular interest in cannabidiol (CBD) and its therapeutic potential in diabetic heart disease. She is an NRF C2-rated researcher (2025) and recipient of an NRF CSUR grant (2025–2027) supporting research on CBD and inflammation. She has authored or co-authored 27 peer-reviewed journal articles and four book chapters and has supervised three PhD and two MSc students to completion, in addition to several Honours students. Her work integrates mechanistic and translational approaches to studying disease pathways and emerging therapeutic strategies.